A la une
Paris, February 9th 2012 - Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy™ fo...
Lille (France), Cambridge (Massachusetts, United States), February 9, 2012 – GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical compa...
PDF 
